PDEX
Pro-Dex, Inc.
NASDAQ · USHealthcareMedical - Instruments & Supplies
$54.66-4.74%
Price as of Jul 20, 2026
PDEX financials
Pro-Dex, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $66.6M | $53.8M | $46.1M | $42.0M |
| Cost of revenue | $47.1M | $39.3M | $33.3M | $28.9M |
| Gross profit | $19.5M | $14.6M | $12.7M | $13.1M |
| Operating expenses | $8.8M | $7.4M | $7.0M | $8.0M |
| Operating income | $10.7M | $7.2M | $5.8M | $5.1M |
| Net income | $9.0M | $2.1M | $7.1M | $4.6M |
| EBITDA | $14.1M | $4.4M | $10.8M | $6.9M |
| Basic EPS | $2.73 | $0.61 | $1.98 | $1.26 |
| Diluted EPS | $2.67 | $0.60 | $1.95 | $1.21 |
| Balance sheet | ||||
| Cash & equivalents | $419.0K | $2.6M | $2.9M | $849.0K |
| Total assets | $61.2M | $52.5M | $51.8M | $49.1M |
| Total liabilities | $24.6M | $21.6M | $20.2M | $23.7M |
| Stockholders’ equity | $36.6M | $30.9M | $31.6M | $25.4M |
| Total debt | $16.6M | $13.5M | $14.8M | $16.0M |
| Net debt | $16.2M | $10.9M | $11.9M | $15.1M |
| Cash flow | ||||
| Operating cash flow | -$1.7M | $6.2M | $5.5M | -$847.0K |
| Capital expenditure | -$1.2M | -$983.0K | -$974.0K | -$1.7M |
| Free cash flow | -$2.9M | $5.2M | $4.5M | -$2.5M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | -$3.5M | -$3.5M | -$1.5M | -$1.6M |